分类: health

  • Medio 2027 meer laboratoriumonderzoek zelf uitvoeren

    Medio 2027 meer laboratoriumonderzoek zelf uitvoeren

    On October 24, Suriname’s Minister of Public Health, Welfare and Labour André Misiekaba outlined the national government’s new roadmap to upgrade the country’s distributed laboratory network, with a formal target to enable fully independent execution of all critical baseline diagnostic and environmental tests no later than mid-2027, while addressing lawmakers’ questions during a parliamentary sitting of the National Assembly.
    The policy push was directly catalyzed by the large-scale fish mortality event that occurred along the Saramacca River earlier this year, which exposed critical gaps in local testing capacity at the time: authorities were forced to send relevant samples all the way to a laboratory in Cayenne for specialized analysis, as no domestic facility could process the required assessments rapidly enough. In response to that incident, President Jennifer Simons convened a dedicated working meeting that brought together representatives from every operational laboratory across Suriname to map existing capabilities and unmet needs.
    Misiekaba confirmed that Suriname currently hosts roughly nine independent laboratories attached to diverse public institutions, including the National Central Laboratory, the Academic Hospital, the Ministry of Agriculture’s LVV department, the Centre for Agricultural Research in Suriname (CELOS), and the Suriname Water Supply Company. During the initial inter-agency summit, officials completed a full inventory of all tests that local labs can currently run in-house, as well as the high-priority testing categories that remain entirely unavailable domestically.
    The government has now moved past the assessment phase to launch the next stage of the initiative: an international specialized consultant will conduct on-site audits at every participating facility over the coming months, to document existing equipment stock, verify current operational capacity, and pinpoint exact gaps in infrastructure, staffing, and supplies that require targeted investment. The overarching framework is designed not just to add missing equipment, but to create a fully coordinated, interconnected national network that eliminates redundant work and aligns each facility’s specialization to maximize overall efficiency.
    Misiekaba emphasized that as a tropical nation with a major gold mining industry, Suriname faces a uniquely broad set of public health, environmental, and occupational safety risks that demand fast, reliable local diagnostic capacity. Continued reliance on overseas laboratories for urgent testing creates costly delays, slows emergency response, and undermines the country’s ability to rapidly contain public health or ecological crises, he noted. Until the full national network upgrade is completed by the 2027 target, Suriname will maintain its existing formal partnerships with accredited international laboratories to process high-complexity samples, a system currently in use for ongoing avian influenza testing: samples collected from poultry confirmed to carry the virus are sent abroad to identify the exact viral strain and guide containment efforts. The minister acknowledged that the full capacity expansion project will require sustained long-term investment and multi-year implementation work to deliver on all stated goals.

  • Saint Lucia, India sign agreement to expand access to affordable medicines

    Saint Lucia, India sign agreement to expand access to affordable medicines

    Thousands of residents across the Caribbean island nation of Saint Lucia are poised to gain faster, more cost-effective access to life-saving pharmaceutical products, following a newly signed memorandum of understanding (MOU) between the Saint Lucian government and the Indian Pharmacopoeia Commission (IPC), a statutory body operating under India’s Ministry of Health and Family Welfare. The landmark bilateral accord lays out a formal, structured framework for cross-border cooperation on pharmaceutical regulatory practices, as well as systematic information sharing between the two nations’ health authorities. At the core of the new partnership is Saint Lucia’s official formal recognition of the Indian Pharmacopoeia, the official public standard for the quality, safety, and purity of all medicines manufactured and sold in India, as a fully valid benchmark for pharmaceutical products entering its domestic market. This regulatory alignment is set to reinforce the island’s existing medication quality assurance protocols, while simultaneously cutting down lengthy administrative barriers that have long complicated the import of safe pharmaceutical goods from the South Asian pharmaceutical giant. A second critical provision of the MOU eliminates the redundant requirement for locally conducted duplicate laboratory testing for all medicine shipments from Indian manufacturers that operate in full compliance with Indian Pharmacopoeia standards, as Saint Lucian regulators will now directly accept the official certificates of analysis issued by these certified Indian production facilities. Senior health officials from both nations project that these combined regulatory adjustments will drive down overall medication costs for consumers, drastically cut the waiting time for new medication stock to reach local pharmacies, and expand the range of low-cost generic drugs available to patients across the island. India’s High Commissioner to Saint Lucia Subhash Gupta emphasized that the agreement fits into a wider strategy of global public health collaboration aligned with longstanding Indian foreign policy priorities. “By formally recognizing the Indian Pharmacopoeia, Saint Lucia is streamlining the import and quality registration pathways for Indian pharmaceutical products, directly clearing the way for its population to access high-quality, low-cost generic medications that have served communities across the Global East and Global South for decades,” Gupta stated. He further noted that the MOU creates a pathway to adapt India’s world-renowned, massive public medicine distribution network for the Saint Lucian context, with plans for dedicated local outlets that can deliver affordable pharmaceuticals directly to residents. He added that the partnership embodies the traditional Indian cultural principle of Vasudhaiva Kutumbakam, or “the whole world is one family,” and represents a meaningful step toward greater global solidarity on shared public health and well-being goals. For his part, Saint Lucia’s Minister of Health, Wellness and Nutrition Moses Jn. Baptiste framed the MOU as a historic milestone that directly advances his administration’s top domestic policy priority. “This landmark pharmacopoeia agreement is perfectly aligned with our government’s overarching mission to deliver universal, accessible, high-quality health care to every single Saint Lucian citizen, no matter their location or income level,” Jn. Baptiste explained. “By harmonizing a key segment of our pharmaceutical regulatory framework with a globally respected standard, we are immediately unlocking expanded access to safe, affordable, life-saving generic drugs that would have otherwise taken months or years to clear our old import approval processes.” The minister also outlined that the new accord serves as a foundational building block for far-reaching future bilateral health cooperation, opening doors to expanded joint public health initiatives and the procurement of high-priority, hard-to-source medical infrastructure for the island. These planned future projects include expanded national generic drug distribution programs, as well as the acquisition of critical medical assets such as haemodialysis units for kidney care, specialized cancer treatment equipment, and purpose-built sea ambulances to deliver emergency care to residents of Saint Lucia’s more remote coastal communities.

  • Same prescription, different prices: why does the cost of medicines vary?

    Same prescription, different prices: why does the cost of medicines vary?

    A striking, everyday reality plays out across pharmacies in the Dominican Republic: three patients with identical health conditions, holding identical prescriptions for drugs with the exact same therapeutic active ingredient, can end up paying drastically different out-of-pocket costs depending on which retail outlet they visit and which pharmaceutical brand’s formulation they select. This pricing variance is fully legal under the nation’s constitutional framework, which enshrines freedom of enterprise and open market competition, granting commercial pharmacy operators full autonomy to set disparate price points for identical products without facing regulatory penalty. Despite being legally permitted, the widespread uneven pricing structure has sparked growing concern among local patients, many of whom are now forced to earmark an increasingly large share of their limited household income to cover essential pharmaceutical needs. Data aggregated from the public pharmacy price tracking platform Farmacias.do, which compiled reference pricing across 26 common medication SKUs, reveals extreme gaps across nearly every category of widely used over-the-counter and prescription drug. For paracetamol (also known internationally as acetaminophen), a staple pain and fever reducer, 750mg unit prices span from as low as 9.04 pesos for Calox’s formulation, to 12 pesos for the equivalent product from Ibero Fármacos Genéricos, all the way up to 19.65 pesos for the version marketed by MK Laboratories. The gaps are even more pronounced for other active ingredients: 500mg units of the non-steroidal anti-inflammatory mefenamic acid cost 20.75 pesos from MK, but jump to 47.15 pesos for the Colin branded equivalent. 25mg dexketoprofen tablets, another pain relief formulation, show an even starker range, running from 31.98 pesos for Mamey Pharma’s offering, up to 90.98 pesos for Dextrium’s version, a nearly 200% price difference for the same milligram dosage. Other widely prescribed medications follow the same pattern: 500mg amoxicillin antibiotic units start at just 6.06 pesos for Caplin’s formulation, but climb as high as 17.47 pesos for LAM’s equivalent product. 20mg omeprazole, used to manage excess stomach acid and related gastrointestinal conditions, ranges from 4.80 pesos per unit for Caplin Point’s offering to 13.32 pesos for Ibero Fármacos’s version. Even anti-allergy and anti-parasitic treatments carry uneven pricing: 10mg cetirizine allergy tablets range from 12.80 pesos to 18.36 pesos across different brands, while 400mg albendazole antiparasitic tablets cost 19.57 pesos from Colin and 23.40 pesos from Alfa Genéricos. The public Farmacias.do platform allows users to search for specific medications, filter by active ingredient or pharmaceutical lab, and sort results by ascending or descending price to compare available options, though the dataset notes all listed values are reference benchmarks, not real-time quotes, and patients are advised to confirm exact pricing, product formulation, and stock availability at their local pharmacy before purchasing, as variations in packaging or dosage form do not always guarantee full interchangeability between products.

  • PAHO waarschuwt voor risico op terugkeer polio door achterblijvende vaccinatiegraad

    PAHO waarschuwt voor risico op terugkeer polio door achterblijvende vaccinatiegraad

    Marked in conjunction with World Polio Day observed on October 24, the Pan American Health Organization (PAHO) has issued an urgent public health call for nations across the Americas to close persistent polio immunization gaps and strengthen cross-regional disease surveillance, 35 years after the Western Hemisphere was formally certified free of indigenous wild poliovirus transmission.
    While the region celebrated the landmark 1994 designation as the world’s first territory to eliminate local wild polio spread, PAHO data from 2025 shows that childhood immunization coverage remains well below the 95% global threshold required for herd immunity. Across the full Americas region, 91% of children received their first dose of the inactivated poliovirus vaccine (IPV), 89% completed the second dose, and only 87% received the full three-dose primary series. Though these figures represent a steady improvement over previous under-vaccination periods, they still fall short of the international protective target that blocks community circulation of the highly contagious neurotropic virus.
    Suriname emerges as a key priority area in the PAHO update: latest joint WHO and UNICEF immunization estimates for 2025 show the country’s first-dose IPV coverage stands at just 78%, with full primary series completion reaching only 76%, far below the 95% benchmark. Health officials emphasize these low rates do not signal an ongoing polio outbreak in Suriname, but create a vulnerable population of under-protected children at elevated risk if the virus is introduced. To address these gaps, Suriname formally established its National Immunization Technical Advisory Group (NITAG) in February 2026, a scientific advisory body that will deliver evidence-based policy guidance to the Ministry of Public Health, Welfare and Labor, with PAHO providing dedicated technical support and standardized operational guidelines.
    PAHO Director Jarbas Barbosa stressed that the region’s 30-plus year track record without a locally acquired wild polio case is a historic public health milestone that cannot be taken for granted. The last confirmed indigenous wild polio case in the Americas was recorded on August 23, 1991, in Peru, affecting an unvaccinated two-year-old child who developed permanent paralysis. That victory followed decades of coordinated mass vaccination campaigns, expanded equitable access to immunization services, and cross-border public health collaboration that drove reported polio cases down from nearly 6,000 across the region in 1975 to zero local transmission.
    Global polio eradication efforts remain incomplete, however: wild poliovirus still circulates endemically in Afghanistan and Pakistan. As of October 20, 2026, 48 confirmed wild polio cases have been documented worldwide, with 42 in Afghanistan and 6 in Pakistan. As long as the virus persists anywhere on the planet, all under-vaccinated communities face importation risk, as the highly transmissible pathogen can re-establish local spread rapidly in populations with low immunity.
    PAHO also highlighted critical gaps in regional polio surveillance systems. Standard public health monitoring for polio relies on tracking cases of acute flaccid paralysis (AFP) – a sudden loss of muscle strength that serves as a key early warning marker for potential polio infection. The international surveillance standard requires a reporting rate of at least 1 AFP case per 100,000 children under the age of 15, but the Americas region recorded only 0.85 cases per 100,000 in the most recent 12-month reporting period, indicating under-detection that could delay identification of imported virus circulation.
    Poliovirus is a highly contagious pathogen that disproportionately targets children under five, attacking the nervous system to cause permanent paralysis within days, and can prove fatal if it paralyzes respiratory muscles. No curative treatment exists for polio once symptoms appear, making full, timely vaccination the only effective protective measure. PAHO is urging all parents and caregivers to verify their children’s immunization schedules, catch up on any missed polio vaccine doses immediately, and support local public health efforts to maintain the region’s decades-long polio-free progress.

  • Ex-director: I warned minister

    Ex-director: I warned minister

    A cascade of resignations has completely dissolved the board of the South West Regional Health Authority (SWRHA) in Trinidad and Tobago, a development that unfolded over the span of just two recent weeks. The exodus began with three core members stepping down: board chairman Anil Gosine, director Dr. Anand Chattergoon, and member Sinanan Dass, all of whom had received their official appointments to the body in the prior year. Gosine cited personal, undisclosed reasons for his departure when he spoke to local outlet the Express at the time of his initial resignation, declining to share additional context. Chattergoon, by contrast, noted he was stepping away to advance a national-level initiative that he argued would deliver tangible improvements to the country’s entire public healthcare network. In the days following these three exits, every remaining board member also submitted their formal resignations, leaving the SWRHA with no sitting governing body in place. Per the Regional Health Authority Act’s second schedule, a properly constituted SWRHA board must hold between seven and nine members, all formally appointed by the national President. In a recent phone interview with the Express, Chattergoon shared that he took action the moment the number of remaining board members dropped to five, well below the legal minimum quorum for valid operations: he sent a formal letter to Health Minister Lackram Bodoe and copied Prime Minister Keith Rowley via email to flag that the board had ceased to be a legally recognized entity. “I warned the minister explicitly that he was in significant jeopardy,” Chattergoon recounted. “Without a functioning board acting as a check on the chief executive officer, any unlawful or improper decisions the CEO makes will have no governing body to serve as a buffer, and the minister will be held directly liable for those missteps. I flagged that this scenario could lead to embarrassing, legally fraught outcomes that would put him in professional and political trouble.” Chattergoon emphasized that his outreach was motivated by personal regard for the minister, rather than a desire to confront or criticize, and that he did not expect a formal response to his correspondence. He outlined that under standard SWRHA governance rules, the elected board holds exclusive authority to set organizational policy, oversee long-term strategy, govern internal operations, and take disciplinary action against the CEO when required. With no board in place, the health minister will be forced to assume full interim oversight of the SWRHA’s operations. “The law clearly states the CEO reports directly to the board, so my biggest concern is who is left to hold the CEO accountable when there is no board in the room?” Chattergoon explained. “That is an extremely high-risk situation: an unsupervised CEO running the entire regional health authority with no formal oversight mechanism, and every choice they make now falls directly on the minister’s shoulders.” He also noted that the Medical Professional Association of Trinidad and Tobago (MPATT) had previously raised formal objections to a specific physician appointment at the SWRHA, a process that per internal policy requires explicit board approval. With no governing body in place, the CEO now has unilateral power to sign off on executive and senior staff appointments without independent review, a loophole Chattergoon warned could quickly expose the authority to costly legal challenges. Chattergoon clarified that there was no coordinated, collective decision for all board members to resign at the same time, so he had no insight into the personal motivations that led other members to step down. For his part, he said he had grown increasingly uncomfortable remaining in his board role, and chose to resign to dedicate his full attention to rolling out a standardized client feedback system that he hopes to implement across every regional health authority nationwide to improve patient care quality. When the Express reached out to Health Minister Bodoe for official comment on the dissolved board and the urgent calls to appoint a new governing body, no response had been received at press time.

  • Bodoe: $33m  for CDAP drugs

    Bodoe: $33m for CDAP drugs

    During a Thursday session of Trinidad and Tobago’s Standing Finance Committee, Health Minister Dr Lakram Bodoe delivered key updates on public health spending, ongoing medication access challenges, and national emergency preparedness while fielding targeted queries from Diego Martin West MP Hans Des Vignes. Bodoe confirmed the government’s fiscal 2027 budget projection for the Chronic Disease Assistance Programme (CDAP) pharmaceutical costs sits at $33 million, marking a notable uptick from the $29.9 million expended on the programme’s medications in the 2026 fiscal year. The hearing was convened to conduct line-by-line scrutiny of the Ministry of Health’s upcoming budget allocation. Des Vignes opened his line of questioning by pressing for clarity on whether the recently revised CDAP medication formulary would resolve persistent supply gaps that have disrupted care for patients managing chronic conditions including cardiovascular disease and various forms of cancer. In response, Bodoe outlined that the administration completed a full review of the long-running CDAP list to phase out older, less effective drug formulations in favor of more advanced therapeutic alternatives, while keeping the total number of covered core chronic disease treatments at 52 items. He emphasized that 49 of the 52 listed medications are currently in steady supply, with only three narrow chronic disease categories facing intermittent shortages at the time of the update. The nationwide CDAP network serves roughly 300,000 registered citizens across 289 partnered private retail pharmacies, according to the minister. Bodoe acknowledged that some patients may encounter out-of-stock notices at their nearest local pharmacy, but noted that formal cross-pharmacy coordination protocols are already active to redirect patients to nearby locations with the required medication on hand. He cited a recent case reported to his office the Wednesday prior, where a resident unable to access their prescription at their neighborhood pharmacy successfully secured the treatment at a different participating outlet through the established referral process. Bodoe also reassured the public that clinically equivalent alternative medications are available for all items facing temporary supply disruptions, to prevent gaps in patient care. Shifting to specialized care allocations, the minister confirmed a dedicated $35 million line item has been earmarked exclusively for oncology radiation therapy services, covering treatment costs for local cancer patients receiving care at designated public health institutions. When Des Vignes raised concerns over whether the $1.145 billion allocation to the North West Regional Health Authority (NWRHA) would be sufficient to cover full staffing rosters, consistent drug stock, and uninterrupted operations at the St James oncology centre, Bodoe confirmed the budget line is structured to cover all personnel salaries, medical supplies, utility costs, security services, and operational expenses for the facility, and would be fully adequate. He extended the same guarantee of sufficient funding to the North Central Regional Health Authority, following a parallel line of questioning. The final segment of the exchange addressed emerging global public health risks, after Des Vignes referenced a recent confirmed human fatality in France linked to the Shamonda virus – a pathogen spread by biting midges that historically primarily impacted livestock populations. Des Vignes pressed the minister on whether Trinidad and Tobago has a coordinated response plan in place if the virus were to reach the country’s borders. Bodoe clarified that the national Disaster Preparedness Coordinating Unit focuses primarily on natural disaster response, while all communicable disease surveillance and outbreak response protocols fall under the oversight of the Office of the Chief Medical Officer, before confirming that the country has all required frameworks in place to mount a rapid, effective response if the virus is detected locally.

  • Misiekaba wil verpleegkundigenopleiding uitbreiden naar Brokopondo en Wanica

    Misiekaba wil verpleegkundigenopleiding uitbreiden naar Brokopondo en Wanica

    Suriname’s Minister of Public Health, Welfare and Labour André Misiekaba announced a phased, nationwide decentralization of nursing education programs during a recent parliamentary session in De Nationale Assemblée, as the government moves to address longstanding critical shortages of frontline care workers across regional districts. The first decentralized training cohort is already operational in the Marowijne district, where 41 local young learners are enrolled in mid-level (BO) nursing tracks, with an additional smaller group pursuing higher professional (hbo) level nursing qualifications. The first graduation ceremony for this inaugural Marowijne cohort is scheduled for the end of December 2029. To enrich hands-on learning for Marowijne trainees, the ministry has formalized a cross-border partnership that places students for clinical rotations at a healthcare facility in Saint-Laurent-du-Maroni, French Guiana, offering them expanded practical experience opportunities. Misiekaba noted that the localized training model is designed to build a stable, homegrown nursing workforce in the district, rather than forcing local residents to travel to the capital for education, which will directly strengthen regional primary care capacity. The government has already begun preparatory work to launch a parallel nursing training program in the Brokopondo district, targeting a March 2027 launch date, following high levels of demonstrated interest from dozens of local young people in the area. After the Brokopondo site becomes operational, the ministry will extend the program to the Wanica district, a move explicitly aligned with projected staffing gaps at the Wanica Hospital. Misiekaba also contextualized the expansion plans by noting the very high global demand for qualified Surinamese nurses, a trend that has driven significant numbers of trained local care workers to seek higher-paying positions abroad. By scaling up decentralized training capacity, the government aims to produce enough new nursing graduates to maintain a sufficient domestic workforce for Suriname’s own healthcare system, even as a portion of newly qualified professionals pursue international career opportunities.

  • Reactie op artikel assembleelid Sadi

    Reactie op artikel assembleelid Sadi

    Published on 23 October at 22:52, this public response from Orlando Cairo addresses a previously published opinion piece that demanded immediate government action following repeated European Union rejections of Suriname’s exported sopropo, red pepper, and yardlong beans. While Cairo shares full concern over the public health risks of these rejected shipments – particularly for vulnerable groups including pregnant people and young children – he pushes back against calls to rush through the proposed National Institute for Food Safety (NIVS) Act, warning that the poorly drafted legislation would exacerbate existing structural gaps rather than resolve them.

    Cairo first corrects widespread misinformation about the long-delayed residual testing laboratory, a key piece of infrastructure for food safety oversight. He notes that contrary to claims the facility’s ongoing construction is a political excuse, the previous administration left an unpaid SRD 32 million bill with the project contractor that stalled progress for years; the current government has since settled that outstanding debt, completed all structural construction work on the lab, and is now in the procurement phase for high-precision testing equipment. He also clarifies critical regulatory distinctions often omitted in public debate: the European Union will not mandate mandatory residual certification for imported plant-based products until 2030, and until that date, valid phytosanitary certificates issued under Suriname’s 2020 Plant Protection Act and aligned with IPPC international guidelines are fully compliant. These certificates fall under the explicit purview of the National Plant Protection Organization (NPPO), not the NIVS, as the two documents operate on separate legal foundations, follow different inspection protocols, and serve distinct regulatory purposes.

    Cairo then outlines the core structural flaws of the proposed NIVS Act that he argues make it a dangerous policy choice. Under Article 20 of the draft legislation, the NIVS supervisory board would grant private sector representatives a two-thirds majority, outnumbering the three directors from relevant government ministries. This would place the very producers, processors, and sellers of food products in charge of regulating their own industry, creating a fundamental conflict of interest where oversight bodies would effectively be allowed to “police their own meat.” He also points out that the Suriname Standards Bureau (SSB) has maintained a national pre-packaged food labeling standard fully aligned with Codex Alimentarius international guidelines since 2017, meaning granting the NIVS a separate, overlapping labeling mandate would create unnecessary bureaucratic duplication and regulatory confusion. The accompanying draft Food Safety Law referenced in the earlier opinion piece further compounds these issues, as nearly every provision of that bill references the NIVS Act without establishing independent food safety definitions, quality assurance frameworks, or legal bases for export certification, effectively stripping existing competent bodies including the NPPO, the veterinary service, and the Public Health Department (BOG) of their established regulatory authority.

    Cairo notes that the earlier opinion piece, penned by a sitting member of parliament, failed to address the most critical pending policy priority for meaningful food safety reform: the Pesticide Management Law, which has been tabled before the National Assembly since December 2024. Without this legislation, existing public oversight bodies lack the legal mandate to conduct regular on-site visits to agricultural production zones and enforce maximum residual limit (MRL) testing protocols. He also highlights that the current administration has already launched targeted investment programs to upskill inspectors and lab analysts, a core requirement for long-term functional food safety oversight that has been overlooked in recent political debates. He closes by inviting the author of the original opinion piece to join a formal technical working group discussion with frontline regulatory agencies, rather than continuing to frame food safety as a partisan political talking point, noting that Surinamese consumers deserve far better than a flawed law that cedes public health oversight to private industry and undermines years of incremental progress on food safety infrastructure.

  • Saint Lucia needed its own interventional cardiologist. He trained to become one

    Saint Lucia needed its own interventional cardiologist. He trained to become one

    When Lestin Celestin stood at his thesis defense, moments away from formal confirmation of his Master of Interventional Cardiology credential, the choice to accept his promotion carried far greater weight than a routine academic milestone. That formal sign-off would mark the end of years of targeted training, and make Celestin the first and only locally based interventional cardiology specialist in Saint Lucia, poised to address a long-unmet need in the island nation’s public health ecosystem.

    Interventional cardiologists are highly trained medical professionals who treat life-threatening conditions including ischaemic heart disease, a widespread ailment that develops when the arteries supplying blood to the heart narrow or become blocked, triggering heart attacks and cascading long-term complications such as heart failure. Using precise, minimally invasive procedures, these specialists can restore blood flow to damaged cardiac tissue, drastically reduce patient risk of permanent harm, and drastically improve long-term health outcomes for people living with cardiac conditions.

    For years, Saint Lucia has lacked widespread, accessible access to these life-saving services. The only interventional cardiology care available on the island is offered at the private Tapion Hospital, delivered by overseas-based specialists who make periodic, limited visits, leaving most local patients with no reliable, timely pathway to this critical care. Unlike peer Caribbean nations Barbados and Trinidad and Tobago, which operate fully functional cardiac catheterization labs integrated into their public healthcare networks, Saint Lucia’s major public hospital facilities have no dedicated units for these specialized procedures.

    Celestin, who completed his latest advanced training at Havana’s Instituto de Cardiología y Cirugía Cardiovascular, remains undeterred by that systemic gap, and is convinced building a local public-facing interventional cardiology service is a feasible, achievable goal. “Setting up a dedicated lab is far less resource-intensive than many other specialized medical units,” he explained in an interview with the *St Lucia Times*. “Full cardiac surgery requires a massive, multi-disciplinary team, but interventional cardiology only needs a well-trained, cohesive group of staff. This is absolutely something we can build in Saint Lucia. My core priority is to help our country reach a point where all residents can access this high-level specialized care, particularly for life-threatening ischaemic heart disease.”

    That driving vision carried Celestin through 18 months of grueling study in Cuba, a period marked by severe daily hardships driven by intensified U.S. sanctions, widespread fuel shortages, rolling multi-hour power outages and broader economic crisis across the island. His determination to fill the unmet need back home was also the core motivation that pushed him to compete for the highly selective specialized medical placement in the first place. “I have no opposition to private healthcare, but I believe far more Saint Lucian families deserve reliable access to these life-saving interventions,” he noted.

    Celestin’s path to this milestone stretches back to 2019, when he graduated as a general medical doctor from Cienfuegos Medical Science University (CMSU) under the bilateral Saint Lucia-Cuba scholarship programme, before returning home to complete clinical residencies at Saint Lucian healthcare facilities. He then went back to Cuba to earn his Clinical Cardiology Specialist Degree from CMSU, before enrolling in the competitive interventional cardiology master’s programme in January 2025. He was only able to secure a partial merit-based scholarship for this final phase of training, requiring him to cover the remaining financial costs out of pocket, a burden he says was fully justified by the outcome. “I felt far more joy graduating as an interventional cardiologist than I did when I finished my general cardiology qualification, because this is the milestone I have been working toward for years,” he shared. Over the 18-month programme, he gained extensive hands-on clinical experience working alongside Cuban care teams, supporting no fewer than five interventional cardiology cases per day.

    Celestin is currently in the process of formalizing the translation and accreditation of his Cuban qualifications to meet regional medical regulatory requirements. While he has already received preliminary career offers from across the Caribbean via professional colleagues, his top priority remains bringing his newly honed expertise back to his home country to build the long-missed public interventional cardiology service for Saint Lucian residents.

  • Volksgezondheid waarschuwt voor herintroductie malaria door stijging importgevallen

    Volksgezondheid waarschuwt voor herintroductie malaria door stijging importgevallen

    On October 22, 2025, Suriname’s Director of Public Health Rakesh Gajadhar Sukul shared critical updates during an interview with the Suriname Communication Service, revealing that the South American nation has recorded more than double the number of imported malaria cases in 2026 compared to the same period the previous year. The country now sees an average of 10 imported malaria cases per month, with some months reporting upwards of 15 confirmed infections. This trend poses a direct threat to the historic public health milestone Suriname achieved in June 2025, when the World Health Organization formally granted it malaria-free status, making it the first nation across the entire Amazon basin to earn that global recognition. For over five consecutive years prior to that certification, Suriname had documented zero instances of local, domestic malaria transmission. All current imported cases involve individuals who contracted the malaria parasite outside Suriname’s borders before entering the country, with the vast majority originating from neighboring Guyana, followed by secondary sources in Brazil and French Guiana. Data from the national Malaria Program shows that more than 60% of these 2026 imported cases are linked to gold prospectors, primarily traveling from Guyana. While an isolated imported case does not automatically spark a new local outbreak, public health officials warn that the transmission chain can easily restart: an infected person bitten by a malaria-carrying Anopheles mosquito in areas where the insect is present will let the parasite spread to that mosquito, which can then pass the infection to other local residents. Remote gold mining zones and other inland regions with established Anopheles populations are identified as high-priority surveillance sites requiring constant monitoring. To safeguard its hard-won malaria-free status, Suriname’s Ministry of Public Health, Welfare and Labor has deployed dedicated Malaria Program staff to conduct proactive early detection screenings, particularly in border regions and high-risk mining areas. Regular training sessions are also being rolled out for frontline doctors to help them recognize malaria symptoms rapidly and refer patients for life-saving treatment without delays. Director Gajadhar Sukul emphasized that timely diagnosis and immediate targeted treatment are the most critical defenses against the reestablishment of local transmission, noting that full prevention of all imported cases is practically impossible due to the high volume of cross-border human movement across the Amazon region. Health authorities are urging all residents who have traveled to malaria-endemic areas to remain vigilant for common symptoms including fever, chills and headache, and to seek immediate testing and medical care if they develop any signs of illness after returning from high-risk zones. The public is also encouraged to support peers and community members who may have worked in neighboring countries or remote mining sites to get tested at the first sign of potential infection. Beyond domestic measures, Suriname is deepening cross-border partnerships with regional neighbors and global health bodies including the Pan American Health Organization and the Amazon Cooperation Treaty Organization, which are jointly developing a unified malaria response framework tailored for all Amazon basin nations. Suriname is sharing its successful elimination playbook with regional partners, as officials underline that cross-national collaboration is non-negotiable to address the persistent spillover risk from countries with active local malaria transmission. The national government has also established a dedicated specialized commission to oversee efforts to prevent malaria reintroduction, shifting the country’s public health focus from eliminating the disease entirely to protecting the historic public health gains it has secured.